Stephanie Hall
Psychiatry · Louisville, KYNPI 1952521007
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $100,225 of the $105,694 with a category attached, or 94.8%. AbbVie accounts for 98.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $35,220 and has fallen 80.1% since, to $7,013 in 2025. Among psychiatry clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 322 payments — averaging $328.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$104K
- Supernus Pharmaceuticals, Inc.$300
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$219
- Axsome Therapeutics, Inc.$215
- Ironshore Pharmaceuticals Inc.$133
- Johnson & Johnson$119
- plus $256 from 7 others
What the payments were for
- Speaking & faculty fees$100,22595%
- Travel & lodging$2,1602%
- Food & beverage$3,2253%
- Education$840%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 237 | $104,453 |
| Supernus Pharmaceuticals, Inc. | 47 | $300 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $219 |
| Axsome Therapeutics, Inc. | 12 | $215 |
| Ironshore Pharmaceuticals Inc. | 1 | $133 |
| Johnson & Johnson | 4 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Bausch Health US, LLC | 5 | $81 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$102,167
- VIIBRYD$200
- Jornay PM 20mg capsules (Bottle of 100)$133
- CAPLYTA$116
How this compares
$105,694 in reported general payments places this provider in the 95th percentile of 348 psychiatry providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 12 | $28,252 |
| CaplytaLumateperone Tosylate | 15 | $24,429 |
| AuvelityDextromethorphan Hbr/Bupropion | 19 | $22,034 |
| VyvanseLisdexamfetamine Dimesylate | 14 | $5,398 |
| Lisdexamfetamine Dimesylate | 18 | $4,915 |
| Bupropion XlBupropion Hcl | 147 | $3,737 |
| Vilazodone Hcl | 16 | $2,633 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 41 | $2,352 |
| Duloxetine Hcl | 67 | $2,036 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 50 | $1,468 |
| Clonazepam | 123 | $1,254 |
| Quetiapine Fumarate | 52 | $1,084 |
| Aripiprazole | 53 | $1,042 |
| Mirtazapine | 52 | $852 |
| Clozapine | 16 | $836 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $219 | $24,42915 claims |
| Axsome Therapeutics, Inc.Auvelity | $215 | $22,03419 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $95 | $5,39814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 348 psychiatry providers in Kentucky.
Other psychiatry in Louisville
- Rifaat El-MallakhLouisville$1.6M
- Robert StewartLouisville$651K
- Ali FarooquiLouisville$393K
- Kelly ClarkLouisville$14K
- Michael HarrisLouisville$13K
- Yelena VaninaLouisville$12K
- Mohamed KhodeirLouisville$9K
- Kevin BaysLouisville$9K
- Terry HaganLouisville$8K
- Ronald McGavicLouisville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.